Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CRS vs GSK✓SelectedUSD · GSKCRS vs GSK performance historyLatest closeAs of-5.17%11/20
Stock and ETF performance explorer

CRS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+755.8%
GSK return
+40.7%
Excess return
+715.1%
Maximum drawdown
-58.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.2%-0.1%-5.0%-5.1%
7D-12.9%-5.3%-7.6%-11.8%
30D-31.0%-3.7%-27.3%-30.5%
3M-48.0%-7.3%-40.8%-47.2%
6M-39.8%-4.2%-35.5%-39.5%
YTD-19.2%+0.9%-20.0%-19.5%
1Y-16.7%+7.3%-23.9%-18.1%
3Y+277.7%+52.7%+224.9%+230.8%
All+755.8%+40.7%+715.1%+598.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling